-
August 26, 2022 Breaking: Canadian Minister Meets with the Oregon Psilocybin Advisory BoardThe Canadian Minister of Mental Health and Addictions met with members of the Oregon psilocybin...
-
July 19, 2022 Canada Halts MDMA Clinical Trial Over Concerns for Participant SafetyDeficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in...
-
May 31, 2022 British Columbia to Decriminalize Possession of Most DrugsThose caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not...
-
May 25, 2022 Psychedelic Medicine Has Institutional Buy-In & 4 More Catalyst Summit TakeawaysAfter leaving the Catalyst Summit, I am more confident than ever in the governmental and...
-
February 1, 2022 How Psychedelic Treatment Through Canada’s SAP WorksTwo psychedelic industry insiders reflect on the progress and flaws within Health Canada's recent amendment...
-
January 21, 2022 Psychedelic Business Spotlight – January 21Catch up on some of the biggest psychedelic business developments that unfolded in the last...
-
January 4, 2022 Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyNew amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for...
-
November 11, 2021 Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy SessionAnd the results, according to the participants, were nothing short of "profound."
-
November 10, 2021 MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into CanadaRick Doblin's organization partners with Numinus Wellness to manage the Canadian sites where therapists will...
-
September 9, 2021 University of Ottawa Offers Canada’s First Psychedelic Studies ProgramAnd since the classes are online, students can live anywhere in the world while taking...
